Folate, homocysteine and methionine loading in patients on carbamazepine (Q43591766)

25 November 2017

title

Folate, homocysteine and methionine loading in patients on carbamazepine (English)

1 reference

25 November 2017

1 reference

Apeland T

1

1 reference

25 November 2017

Mansoor MA

2

1 reference

25 November 2017

Strandjord RE

3

1 reference

25 November 2017

Vefring H

4

1 reference

25 November 2017

Kristensen O

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Acta Neurologica Scandinavica

25 November 2017

published in

1 reference

25 November 2017

volume

103

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

294-299

1 reference

Reinterpretation of the haematological effects of anticonvulsant treatment

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Elevated plasma concentrations of homocysteine in antiepileptic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Homocysteine concentrations and methionine loading in patients on antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Case-Control Study of Associated Conditions at the Time of Death in Patients with Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Methionine loading test is necessary for detection of hyperhomocysteinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Hyperhomocysteinaemia and premature coronary artery disease in the Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

Homocyst(e)ine levels in patients on phenytoin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

7 January 2021

Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

7 January 2021

Heart disease mortality and morbidity in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

7 January 2021

Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

7 January 2021

Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

7 January 2021

Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

7 January 2021

Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

7 January 2021

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

7 January 2021

Basic haematological parameters, serum gamma-glutamyl-transferase activity, and erythrocyte folate and serum vitamin B12 levels during carbamazepine and oxcarbazepine therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

7 January 2021

The effects of carbamazepine and valproate on folate metabolism in man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005294.X

7 January 2021

10.1034/J.1600-0404.2001.103005294.X

Identifiers

DOI

1 reference

25 November 2017

1 reference